| Literature DB >> 31093753 |
D Ferguson1, A Palmer2, S Khan3, U Oduoza2, H Atkinson4.
Abstract
BACKGROUND: Anterior cruciate ligament (ACL) reconstruction is a rapidly developing orthopaedic field and an area of notable clinical equipoise. The optimal timing of surgery in an acute (< 3 weeks) or delayed (≥ 3 weeks) time frame remains unresolved with a 2010 meta-analysis concluding no difference between these two groups across multiple outcomes. In an era of evidence-based medicine, surgeons are still basing their decisions on when to operate on little more than anecdotal evidence and personal preference. Clear guidance is required to determine whether the timing of surgery can optimise outcomes in this largely young and active patient cohort.Entities:
Keywords: Anterior cruciate ligament; Meta-analysis; Reconstruction; Timing of reconstruction
Mesh:
Year: 2019 PMID: 31093753 PMCID: PMC6647395 DOI: 10.1007/s00590-019-02442-2
Source DB: PubMed Journal: Eur J Orthop Surg Traumatol ISSN: 1633-8065
Fig. 1PRISMA flowchart of study selection
Demographics and study characteristics
| Author and sample size | Injury to surgery interval | Age (years) | Follow-up | Graft | Follow-up (months) | ||
|---|---|---|---|---|---|---|---|
| Early | Delayed | Early | Delayed | ||||
| 1 Raviraj [ | < 2 weeks | 4–6 weeks | 31.6 ± 5.3 | 31.2 ± 5.3 | 94 ( | STG | 32 |
| 2 Li [ | < 3 weeks | ≥ 3 weeks | 24.3 ± 4.9 | 26.5 ± 5.7 | 100 ( | ST | 24 |
| 3a Herbst [ | 1.1 ± 0.7 days | 53.9 (SD ± 68.4 days) | 27.6 ± 11.0 | 27.8 ± 10.6 | 99 ( | HT | 24 |
| 3b Herbst [ | 0.8 ± 0.8 days | 49.2 (SD ± 86.3 days) | 24.9 ± 7.9 | 24.7 ± 10.6 | 100 ( | HT | 24 |
| 4 Manandhar [ | < 3 weeks | 42 (42–60 days) | n/s | n/s | 96 ( | STG | 6 |
| 5 Hur [ | < 3 weeks | ≥ 3 months | 30.1 | 30.0 | 100 ( | HT | 24 |
| 6 Karuppiah [ | < 2 weeks | ≥ 3 months | 27.3 (15–48) | 25.4 (15–46) | 98 ( | NS | 11 |
SD, standard deviation, graft type; STG, semitendinosus and gracilis; ST, semitendinosus; HT, hamstring tendon; NS, not stated
aIsolated ACL tear, bcombined ACL and meniscal tear
Results of meta-analyses of early versus delayed ACL reconstruction
| Outcome | Papers | Relative risk (95% CI) | Overall effect ( | Heterogeneity ( |
|---|---|---|---|---|
| Tegner activity scale | 2, 3a, 3b, 4, 5 | 0.39 (0.10, 0.67)* | 0.008 | 0 |
| Lysholm score | 2, 3, 5 | − 0.18 (− 2.40, 2.05)* | 0.88 | 21 |
| Meniscal lesion incidence | 1, 2, 3b, 4, 5 | 0.84 (0.66, 1.08) | 0.17 | 49 |
| Chondral lesion incidence | 1, 2, 4, 5 | 0.56 (0.31, 1.02) | 0.06 | 73 |
*Mean difference (95 confidence intervals)
Fig. 2Summary of methodological characteristics of the included studies as per Downs and Black checklist [32]
| Authors | Design |
|
|---|---|---|
| 1. Raviraj et al. [ | Randomised control trial | Lysholm score—at 26–36 months Tegner score—at 26–36 months Stability—Lachman, pivot shift, anterior draw, varus/valgus test, KT-1000 arthrometer at 26–36 months Meniscal injury—at time of surgery Chondral injury—at time of surgery |
| 2. Li et al. [ | Retrospective cohort | Tegner score—preoperative and 24 months IKDC score—preoperative and 24 months ROM—preoperative and 24 months Stability—kneelax arthrometer—preoperative and 24 months Meniscal/chondral lesion—at time of surgery |
| 3^. Herbst et al. [ | Prospective non-randomised trial | IKDC score—preoperative and 24 months VAS pain—preoperative and 24 months ROM—preoperative and 24 months Stability—Lachman, anterior draw, pivot shift—preoperative and 24 months Cyclops lesion—at time of surgery Meniscal repair failure—within 24 months ACL graft rupture—within 24 months IKDC objective—at 24 months |
| 3*. Herbst et al. [ | Prospective non-randomised trial | IKDC score—preoperative and 24 months VAS pain—preoperative and 24 months ROM—preoperative and 24 months Stability—Lachman, anterior draw, pivot shift—preoperative and 24 months Meniscal injury—at time of surgery Cyclops lesion—at time of surgery Meniscal repair failure—within 24 months ACL graft rupture—within 24 months IKDC objective—at 24 months |
| 4. Manandhar et al. [ | Randomised control trial | Tegner—6 months IKDC subjective—6 months Meniscal/chondral lesion at time of surgery |
| 5. Hur et al. [ | Prospective non-randomised trial |
ROM—at 24 months Tegner—pre-injury and 24 months Meniscal/chondral lesion—at time of surgery Muscle power—at 24 months Pivot shift—preoperative and 24 months Lachman—preoperative and 24 months IKDC—variant not stated |
| 6. Karuppiah et al. [ | Retrospective cohort | Post-operative complications—at 11 months |
| Study or subgroup | Early | Delayed | Weight (%) | Mean difference | Mean difference | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Total | Mean | SD | Total | ||||
| Herbst et al. [ | 6.7 | 1.3 | 50 | 6.3 | 1.4 | 50 | 28.9 | 0.40 [− 0.13, 0.93] |
|
| Herbst et al. [ | 6.6 | 1.2 | 30 | 6.3 | 1.5 | 30 | 17.2 | 0.30 [− 0.39, 0.99] | |
| Hur et al. [ | 6 | 1.6 | 48 | 5.6 | 1.5 | 43 | 20.0 | 0.40 [− 0.24, 1.04] | |
| Li et al. [ | 6.6 | 1.9 | 17 | 6.3 | 1.8 | 21 | 5.8 | 0.30 [− 0.89, 1.49] | |
| Manandhar et al. [ | 4.15 | 1.45 | 53 | 3.72 | 1.34 | 51 | 28.2 | 0.43 [− 0.11, 0.97] | |
| Total (95% CI) | 198 | 195 | 100.0 | 0.39 [0.10, 0.67] | |||||
| Heterogeneity. | |||||||||
| Test for overall effect: Z = 2.65 ( | |||||||||
| Study or subgroup | Early | Delayed | Weight (%) | Mean difference | Mean difference | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Total | Mean | SD | Total | ||||
| Herbst et al. [ | 93.1 | 8.5 | 50 | 92.4 | 6.8 | 50 | 39.9 | 0.70 [− 2.23, 3.72] |
|
| Hur et al. [ | 94.5 | 8.9 | 48 | 96.3 | 3.7 | 4. | 45.5 | − 1.80 [− 4.55, 0.95] | |
| Li et al. [ | 94.7 | 9.3 | 17 | 92.2 | 7.8 | 21 | 14.6 | 2.50 [− 3.04, 8.04] | |
| Total (95% CI) | 115 | 114 | 100.0 | − 0.18 [− 2.40, 2.05] | |||||
| Heterogeneity. | |||||||||
| Test for overall effect: | |||||||||
| Study or subgroup | Early | Delayed | Weight (%) | Risk ratio | Risk ratio | ||
|---|---|---|---|---|---|---|---|
| Events | Total | Events | Total | M–H, random, 95% CI | M–H, random, 95% CI | ||
| Herbst et al. [ | 30 | 80 | 30 | 80 | 20.4 | 1.00 [0.67, 1.49] |
|
| Hur et al. [ | 25 | 48 | 27 | 43 | 23.0 | 0.83 [0.58, 1.18] | |
| Li et al. [ | 2 | 17 | 9 | 21 | 2.9 | 0.27 [0.07, 1.10] | |
| Manandhar et al. [ | 22 | 51 | 34 | 51 | 22.1 | 0.65 [0.45, 0.94] | |
| Raviraj et al. [ | 38 | 51 | 35 | 48 | 31.6 | 1.02 [0.81, 1.29] | |
| Total (95% CI) | 247 | 243 | 100.0 | 0.84 [0.66, 1.08] | |||
| Total events | 117 | 135 | |||||
| Heterogeneity. | |||||||
| Test for overall effect: | |||||||
| Study or subgroup | Early | Delayed | Weight (%) | Risk ratio | Risk ratio | ||
|---|---|---|---|---|---|---|---|
| Events | Total | Events | Total | M–H, random, 95% CI | M–H, random, 95% CI | ||
| Hur et al. [ | 15 | 48 | 20 | 43 | 30.9 | 0.67 [0.4., 1.14] |
|
| Li et al. [ | 0 | 17 | 7 | 21 | 4.1 | 0.08 [0.00, 1.33] | |
| Manandhar et al. [ | 10 | 53 | 28 | 51 | 28.6 | 0.34 [0.19, 0.63] | |
| Raviraj et al. [ | 29 | 51 | 31 | 48 | 36.4 | 0.88 [0.64, 1.21] | |
| Total (95 CI) | 169 | 163 | 100.0 | 0.56 [0.31, 1.02] | |||
| Total events | 54 | 86 | |||||
| Heterogeneity. | |||||||
| Test for overall effect: | |||||||